Krka Unveils EUR 80m Active Ingredients Plant
Novo Mesto, 12 June - Pharma company Krka presented on Tuesday its EUR 80m plant for the manufacture of active ingredients. The Sinteza 4 plant will enable Slovenia's largest drug maker to produce most of active ingredients by itself, which its CEO Joze Colaric said would increase value added, cut costs and improve its competitive ability.
The rest of this news item is available to subscribers.
The news item consists of 766 characters (without spaces) or 150 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.